TrialThe lancet. HIV2020

Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.

Christine M Durand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.